|
LTRN Lantern Pharma Inc 1763950 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-7,072,124.00 |
| Balance Sheet |
|
Current Assets
|
$8,458,919.00 |
|
Assets
|
$8,602,349.00 |
|
Current Liabilities
|
$4,322,512.00 |
|
Liabilities
|
$11,819,601.00 |
|
Equity
|
$-3,217,252.00 |
|
Shares Out
|
12759146.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-6,713,540.00 |
|
Investing Cash Flow
|
$4,942,250.00 |
| Market Analysis |
Market Cap
|
$29,218,444.34 |
|
Price
|
$2.29 |
|
BVPS
|
0.31 |
|
PB
|
7.39 |
|
EPS
|
-0.57 |
|
FCF
|
$-6,715,255.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:54 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:45 |
|
| Apr |
May |
Jun |
| 2026-03-30 |
-1.57 |
|
|
2026-05-15 |
-0.30 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-13 |
-0.40 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.39 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LTRN documents filed with the SEC.
LTRN Filings
Clear
